A Rational Pipeline for Development of Novel Anti-TB Drug Regimens
Principal Investigator: David Russell
Department of Microbiology and Immunology
Email:
dgr8@cornell.edu
Sponsor:
The Mueller Health Foundation
Title:
A Rational Pipeline for Development of Novel Anti-TB Drug Regimens
Project Amount:
$1,992,356
Project Period:
September 2021
to
August 2025